RAVNANGER APOTEK AS

5310 HAUGLANDSHELLA

Finances

Share Ownership

Return on Equity

91,67 %

Current Ratio

1,14

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	25 171 000	24 828 000	22 084 000	17 908 000
Net Income	1 277 000	1 548 000	1 531 000	467 000
Total Assets	6 404 000	5 654 000	5 413 000	4 003 000
Total Equity	1 393 000	115 000	1 767 000	436 000

Income (NOK)	2022	2021	2020	2019
Revenue	25 171 000	24 828 000	22 084 000	17 908 000
Expenditure	23 534 000	22 839 000	20 116 000	17 286 000
Operating Profit	1 636 000	1 989 000	1 968 000	622 000
Financial Income	4 000	3 000	4 000	1 000
Financial Costs	2 000	8 000	8 000	24 000
Financial Balance	2 000	−5 000	−4 000	−23 000
Earnings Before Tax	1 638 000	1 985 000	1 963 000	599 000
Tax	360 000	437 000	432 000	132 000
Net Income	1 277 000	1 548 000	1 531 000	467 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	700 000	848 000	923 000	1 215 000
Total Current Assets	5 704 000	4 806 000	4 490 000	2 788 000
Total Assets	6 404 000	5 654 000	5 413 000	4 003 000
Total Retained Equity	1 288 000	10 000	1 662 000	331 000
Total Equity	1 393 000	115 000	1 767 000	436 000
Total Long-Term Debt	3 000	399 000	514 000	638 000
Total Current Debt	5 008 000	5 140 000	3 132 000	2 929 000
Total Equity and Debt	6 404 000	5 654 000	5 413 000	4 003 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	25 184 000	24 823 000	22 072 000	17 848 000
Other Income	−13 000	4 000	12 000	61 000
Revenue	25 171 000	24 828 000	22 084 000	17 908 000
Cost of Goods Sold	18 601 000	18 468 000	16 077 000	12 967 000
Salary Costs	3 452 000	3 111 000	2 883 000	3 116 000
Depreciation	255 000	309 000	292 000	292 000
Impairment	0	0	0	0
Expenditure	23 534 000	22 839 000	20 116 000	17 286 000
Operating Profit	1 636 000	1 989 000	1 968 000	622 000
Financial Income	4 000	3 000	4 000	1 000
Financial Costs	2 000	8 000	8 000	24 000
Financial Balance	2 000	−5 000	−4 000	−23 000
Dividends	0	1 550 000	0	400 000
Net Income	1 277 000	1 548 000	1 531 000	467 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	700 000	847 000	922 000	1 214 000
Total Tangible Assets	700 000	847 000	922 000	1 214 000
Total Fiancial Fixed Assets	1 000	1 000	1 000	1 000
Total Fixed Assets	700 000	848 000	923 000	1 215 000
Stock	1 366 000	1 319 000	1 354 000	1 279 000
Total Investments	0	0	0	0
Cash, Bank	3 723 000	2 403 000	2 365 000	1 040 000
Total Current Assets	5 704 000	4 806 000	4 490 000	2 788 000
Total Assets	6 404 000	5 654 000	5 413 000	4 003 000
Total Equity	1 393 000	115 000	1 767 000	436 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	3 000	399 000	514 000	638 000
Creditors	3 850 000	2 313 000	1 914 000	1 595 000
Unpaid Taxes	409 000	413 000	424 000	372 000
Dividends	0	1 550 000	0	400 000
Other Current Debt	371 000	399 000	338 000	415 000
Total Current Debt	5 008 000	5 140 000	3 132 000	2 929 000
Total Equity and Debt	6 404 000	5 654 000	5 413 000	4 003 000

Financial indicators	2022	2021	2020	2019
Return on Equity	91,67 %	1 346,09 %	86,64 %	107,11 %
Debt-to-Equity Ratio	0	3,47	0,29	1,46
Operating Profit Margin	6,5 %	8,01 %	8,91 %	3,47 %
Current Ratio	1,14	0,94	1,43	0,95
Quick Ratio	1,57	1,26	2,53	1,69
Equity Ratio	0,22	0,02	0,33	0,11
Gross Profit Margin	26,1 %	25,62 %	27,2 %	27,59 %